ATLANTA, GA – – (Newsfile Corp. – September 25, 2020) – – Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT) securities between June 25, 2020 and July 25, 2020 (the “Class Period”). Investors who purchased the Company’s securities during the Class Period and are interested in serving as lead plaintiff are encouraged to contact the firm before the October 23, 2020 deadline. The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed (‘OWS’), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart’s COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart’s COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support. If you purchased shares of Vaxart securities between June 25, 2020 and July 25, 2020 and suffered significant losses on that investment, you are encouraged to contact Corey D. Holzer, Esq. at email@example.com or Luke R. Kennedy, Esq. at firstname.lastname@example.org, or through www.holzerlaw.com to discuss your legal rights.